Results of the use of selective adsorption of endotoxin in the complex treatment of surgical sepsis and septic shock.

Abstract

Objective. To estimate the results of the use of LPS-adsorption in the complex treatment of surgical or obstetric sepsis and septic shock and to determine the risk factors for the development of lethal outcomes.

Materials and methods. Since 2014, twenty-nine patients with surgical or obstetric sepsis and septic shock have been treated at the Perm Regional Clinical Hospital using selective endotoxin adsorption in addition to conventional medical therapy. Endotoxin elimination was performed using hemoperfusion with the Alteco LPS Adsorber (Sweden). The patients were divided into two groups according to the final results of the treatment. The data of clinical and laboratory examinations were compared before and 24 hours after LPS elimination.

Results. Based on the correlation analysis, the most significant risk factors for the development of fatal outcomes are identified. It was found that neither the initial scores on the APACHE, SOFA scale, nor the level of CRP, PCT, EAA have a significant correlation with the lethal outcome. The only indicator before LPS-adsorption that has a direct correlation of the average value with the fatal outcome is the initial dose of norepinephrine. In our study, the mortality rate depends on the decrease in SOFA scores and its components in 24 hours after the procedure. Patients with the lower score after LPS-adsorption would have lower mortality. The predictors of ineffectiveness of treatment, despite the LPS-adsorption, were an unreliable decrease in the dose of vasopressors and the level of PCT, light improvements in the oxygenation index, the presence of bacteremia, septic shock and the delayed procedure.

Conclusion. In surviving patients with surgical sepsis and septic shock, the use of LPS-adsorption in complex treatment significantly improved the function of the cardiovascular and respiratory systems, reduced the level of PCT. The risk factors for the development of lethal outcomes were the initial severity of cardiovascular insufficiency, the selective sorption of endotoxin with a delay, the presence of bacteremia, septic shock, insignificant decrease in SOFA scores and the level of PCT after selective sorption of endotoxin.

Keywords

Sepsis / septic shock / LPS-adsorption

References

[1] Urakov A.L., Zolotuhin K.N., Samorodov A.V. Blood endotoxin level in patients with sepsis as an early predictor of mortality. Vestnik anesteziologii i reanimatologii 2018; 15 (3): 79–80 (in Russian).

[2] Ураков А.Л., Золотухин К.Н., Самородов А.В. Уровень эндотоксина крови у пациентов с сепсисом как ранний предиктор летальности. Вестник анестезиологии и реаниматологии. 2018; 15 (3): 79–80.

[3] Podkorytova O.L., Vtorenko V.I., Vetsheva M.S. Selection of optimal modes of extracorporeal detoxification in patients with severe acute pancreatitis. Medicinskij alfavit 2014; 9: 12–16 (in Russian).

[4] Подкорытова О.Л., Вторенко В.И., Ветшева М.С. Выбор оптимальных режимов экстракорпоральной детоксикации у пациентов с тяжелым острым панкреатитом. Медицинский алфавит 2014; 9: 12–16.

[5] Paternoster D., Nagi A. Immunomodulation, immunostimulation and extracorporeal hemocorrection in sepsis: the possibilities of using these technologies in cardiology. Vestnik anesteziologii i reanimatologii 2019; 16 (2): 96–100 (in Russian).

[6] Патерностер Д., Наги А. Иммуномодуляция, иммуностимуляция и экстракорпоральная гемокоррекция при сепсисе: возможности применения данных технологий в кардиологии. Вестник анестезиологии и реаниматологии 2019; 16 (2): 96–100.

[7] Kulabuhov V.V., Chizhov A.G., Kudrjavcev A.N. Selective lipopolysaccharide hemosorption as a key link in pathogenetically justified therapy of gram-negative sepsis. Medicinskij alfavit 2010; 3 (12): 60–66 (in Russian).

[8] Кулабухов В.В., Чижов А.Г., Кудрявцев А.Н. Селективная липополисахаридная гемосорбция как ключевое звено патогенетически обоснованной терапии грамотрицательного сепсиса. Медицинский алфавит 2010; 3 (12): 60–66.

[9] Jarustovskij M.B., Abramjan M.V., Krotenko N.P., Popov D.A., Pljush M.G., Nazarova E.I., Gordeev S.L. Experience of use of endotoxin selective adsorption in patients with heavy sepsis after open-heart surgery. Anesteziologija i reanimatologija 2014; 3: 39–46 (in Russian).

[10] Ярустовский М.Б., Абрамян М.В., Кротенко Н.П., Попов Д.А., Плюш М.Г., Назарова Е.И., Гордеев С.Л. Опыт применения селективной абсорбции эндотоксина у пациентов с тяжелым сепсисом после открытых операций на сердце. Анестезиология и реаниматология 2014; 3: 39–46.

[11] Vatazin A.V., Fomin A.M., Koshelev R.V., Moskalec O.V., Zul'karnaev A.B. Endotoxin selective adsorbtion efficiency in a case of surgical sepsis. Vestnik transplantologii i iskusstvennyh organov 2008; 3 (41): 40–43 (in Russian).

[12] Ватазин А.В., Фомин А.М., Кошелев Р.В., Москалец О.В., Зулькарнаев А.Б. Эффективность селективной экстракорпоральной сорбции эндотоксина грамотрицательных бактерий при хирургическом сепсисе. Вестник трансплантологии и искусственных органов 2008; 3(41): 40–43.

[13] Vatazin A.V., Jarustovskij M.B., Fomin A.M., Koshelev R.V., Zul'karnaev A.B. The first experience of applying selective hemoperfusion in patients with surgical sepsis. Al'manah klinicheskoj mediciny 2008; 18: 22–29 (in Russian).

[14] Ватазин А.В., Ярустовский М.Б., Фомин А.М., Кошелев Р.В., Зулькарнаев А.Б. Первый опыт применения селективной гемоперфузии у больных с хирургическим сепсисом. Альманах клинической медицины 2008; 18: 22–29.

[15] Lipesey M., Tenhunen J., Pischke S.E., Kuitunen A., Flaatten H., De Geer L., Sjolin J., Frithiof R., Chew M.S., Bendel S., Kawati R., Larsson A., Mollnes T.E., Tonnessen T.I., Rubertsson S. Endotoxin removal in septic shock with the Alteko LPS Adsorber was safe but showed no benefits compared to placebo in the double-blind randomized controlled trial – the asset study. Shock. 2020; 54 (2): 224–231.

[16] Lipesey M., Tenhunen J., Pischke S.E., Kuitunen A., Flaatten H., De Geer L., Sjolin J., Frithiof R., Chew M.S., Bendel S., Kawati R., Larsson A., Mollnes T.E., Tonnessen T.I., Rubertsson S. Endotoxin removal in septic shock with the Alteko LPS Adsorber was safe but showed no benefits compared to placebo in the double-blind randomized controlled trial – the asset study. Shock 2020; 54 (2): 224–231.

[17] Sartelli M. et al. The management of intra-abdominal infections from a global perspective: 2017 WSES guidelines for management of intra-abdominal infections. World Journal of Emergency Surgery 2017; 12 (1): 1–34.

[18] Adamik B., Zielinski S., Smiechowicz J., Kubler A. Endotoxin elimination in patients with septic shock: an observation study. Arch Immunol Ther Exp (Warz) 2015; 63 (6): 475–483.

[19] Tellor B., Skrupky L.P., Symons W. et al. Inadequate source control and inappropriate antibiotics are key determinants of mortality in patients with intra-abdominal sepsis and associated bacteremia. Surg Infect 2015; 16 (6): 785–793.

[20] Adamik B., Zielinski S., Smiechowicz J., Kubler A. Endotoxin elimination in patients with septic shock: an observation study. Arch Immunol Ther Exp (Warz) 2015; 63 (6): 475–483.

Funding

ГБУЗ ПК ПККБPerm regional clinical hospital

RIGHTS & PERMISSIONS

Vereshchagin A., Kotelnikova L.P.